Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer

Condition:   Metastatic Colorectal Cancer Interventions:   Drug: Alectinib;   Drug: Cetuximab;   Drug: Crizotinib;   Drug: Dasatinib;   Drug: Everolimus;   Drug: Encorafenib;   Drug: Gemcitabine;   Drug: Idelalisib;   Drug: Larotrectinib;   Drug: Methotrexate;   Drug: Palbociclib;   Drug: Panobinostat;   Drug: Pembrolizumab;   Drug: Petrozumab;   Drug: Trastuzumab;   Drug: Talazoparib;   Drug: Venetoclax Sponsor:   Oslo University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials